Organon & Co.
OGN · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2,777 | $2,516 | $3,840 | $3,845 |
| - Cash | $1 | $599 | $547 | $675 |
| + Debt | $8,828 | $8,896 | $8,956 | $8,880 |
| Enterprise Value | $11,604 | $10,813 | $12,249 | $12,050 |
| Revenue | $1,602 | $1,594 | $1,513 | $1,592 |
| % Growth | 0.5% | 5.4% | -5% | – |
| Gross Profit | $857 | $874 | $841 | $896 |
| % Margin | 53.5% | 54.8% | 55.6% | 56.3% |
| EBITDA | $460 | $449 | $325 | $341 |
| % Margin | 28.7% | 28.2% | 21.5% | 21.4% |
| Net Income | $160 | $145 | $87 | $109 |
| % Margin | 10% | 9.1% | 5.8% | 6.8% |
| EPS Diluted | 0.61 | 0.56 | 0.33 | 0.42 |
| % Growth | 8.9% | 69.7% | -21.4% | – |
| Operating Cash Flow | $264 | $220 | $75 | $390 |
| Capital Expenditures | -$115 | -$39 | -$97 | -$132 |
| Free Cash Flow | $149 | $181 | -$22 | $258 |